Clinical trials
Phase 2/3 Esophageal Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2022 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 7 |
| Unknown status | 7 |
| Terminated | 3 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Tianjin Medical University Cancer Institute and Hospital | 2 |
| Auron Healthcare GmbH | 1 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Centre Georges Francois Leclerc | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Dr. Gordon Buduhan | 1 |
| Eurofarma Laboratorios S.A. | 1 |
| KU Leuven | 1 |
| Lisette Nixon | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Neoplasms | 18 |
| Lung Neoplasms | 3 |
| Adenocarcinoma | 2 |
| Esophageal Squamous Cell Carcinoma | 2 |
| Stomach Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colonic Neoplasms | 1 |
| Gallbladder Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Genital Neoplasms, Female | 1 |
Trials
Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.